Company Overview
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Goulds Water Technology, Jabsco, and Lowara brands. It also provides smart meters, network communication devices, data analytics, test instruments, controls, sensor devices, software and managed services, critical infrastructure services, cloud-based analytics, and remote monitoring and data management under the Ebro, Sensus, Sentec, Smith Blair, WTW, YSI, and Xylem Vue brands. In addition, the company offers preventative maintenance services, rapid response mobile services, digitally enabled/outsourced solutions, process and wastewater treatment systems, environmental remediation, odor and corrosion control, filtration, reverse osmosis, continuous deionization, and mobile dewatering equipment and rental services; and municipal services comprising odor and corrosion control services, as well as condition assessment and asset management, and pressure monitoring solutions under the Grindex, Mar Cor, and Godwin brands. Xylem Inc. was formerly known as ITT WCO, Inc. and changed its name to Xylem Inc. in July 2011. The company was incorporated in 2011 and is headquartered in Washington, District Of Columbia.
Why Investors Should Care
Net profit has compounded at 39.2% per year over the last five years.
Revenue has grown at a 17.8% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.18.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $9.04B (+5.5% YoY); net profit $957.00M.
- Trailing 12 Months Year-on-year growth — revenue +2.7%, earnings +14.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 17.8%, profit CAGR 39.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 17.84% |
| 1 Year: | 2.70% |
Compounded Profit Growth
| 5 Years: | 39.17% |
| 1 Year: | 14.50% |
Stock Price Performance
| 1 Year: | -6.08% |
| 6 Months: | -12.05% |
| 3 Months: | -5.98% |
| 1 Month: | +10.31% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)66.67 · Neutral
P/E of 30.21 is above the sector median of 30.16 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 17.8% over 5 years.
- Profit CAGR of 39.2% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | XYL Xylem Inc. SPX | 121.43 | 30.21 | $28.86B | 1.46% | 8.19% | 8.72% | 17.84% | 39.17% |
| 2 | CAT Caterpillar Inc. SPX | 914.30 | 45.35 | $421.12B | 0.70% | 17.98% | 51.33% | 2.29% | 5.24% |
| 3 | GE GE Aerospace SPX | 360.35 | 44.65 | $375.97B | 0.53% | 11.89% | 45.43% | 16.32% | 195.89% |
| 4 | GEV GE Vernova Inc. SPXAI | 1,055.28 | 30.18 | $283.57B | 0.19% | 6.30% | 75.71% | 8.68% | - |
| 5 | RTX RTX Corporation SPX | 195.89 | 36.68 | $263.80B | 1.51% | 8.28% | 11.57% | 2.61% | 2.62% |
| 6 | BA The Boeing Company SPX | 218.12 | 85.87 | $171.94B | 0.00% | -9.01% | - | 1.67% | -3.28% |
| 7 | UNP Union Pacific Corporation SPX | 288.36 | 23.75 | $171.20B | 1.91% | 15.22% | 40.69% | 2.30% | 7.77% |
| 8 | ETN Eaton Corporation plc SPXAI | 412.86 | 39.13 | $160.31B | 1.06% | 11.53% | 20.84% | 4.73% | 10.38% |
| 9 | DE Deere & Company SPX | 589.48 | 33.40 | $159.22B | 1.11% | - | 18.35% | 3.43% | 5.10% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.38B | 1.45B | 1.72B | 2.08B | 2.03B | 2.17B | 2.10B | - | 2.07B | 2.30B | 2.27B | 2.40B | 2.12B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.30B | 1.41B | 1.39B | 1.47B | 1.32B |
| Gross Profit | 351.00M | 390.00M | 329.00M | 369.00M | 357.00M | 406.00M | 412.00M | 457.00M | 471.00M | 507.00M | 460.00M | 519.00M | 505.00M | 542.00M | 474.00M | 526.00M | 509.00M | 537.00M | 409.00M | 434.00M | 461.00M | 526.00M | 490.00M | 520.00M | 472.00M | 467.00M | 520.00M | 524.00M | 546.00M | 651.00M | 764.00M | 752.00M | 819.00M | 784.00M | - | 768.00M | 892.00M | 883.00M | 932.00M | 803.00M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 516.00M | 561.00M | 526.00M | 546.00M | 528.00M |
| Operating Income | 120.00M | 142.00M | 79.00M | 109.00M | 109.00M | 109.00M | 86.00M | 137.00M | 152.00M | 177.00M | 113.00M | 171.00M | 176.00M | 194.00M | 109.00M | 171.00M | 11.00M | 195.00M | 61.00M | 54.00M | 73.00M | 179.00M | 133.00M | 160.00M | 152.00M | 111.00M | 146.00M | 168.00M | 131.00M | 119.00M | 191.00M | 209.00M | 253.00M | 280.00M | - | 252.00M | 331.00M | 357.00M | 386.00M | 275.00M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 370.00M | 453.00M | 445.00M | 517.00M | 388.00M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.00M | 9.00M | 6.00M | 6.00M | 4.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 217.00M | 299.00M | 297.00M | 368.00M | 244.00M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.00M | 75.00M | 71.00M | 35.00M | 55.00M |
| Net Income | 88.00M | 114.00M | 66.00M | 71.00M | 73.00M | 50.00M | 56.00M | 99.00M | 105.00M | 71.00M | 79.00M | 115.00M | 130.00M | 225.00M | 79.00M | 139.00M | 65.00M | 118.00M | 38.00M | 31.00M | 37.00M | 148.00M | 87.00M | 113.00M | 114.00M | 82.00M | 112.00M | 12.00M | 99.00M | 92.00M | 152.00M | 153.00M | 194.00M | 217.00M | - | 169.00M | 226.00M | 227.00M | 335.00M | 193.00M |
| Diluted EPS | 0.48 | 0.63 | 0.37 | 0.39 | 0.41 | 0.28 | 0.31 | 0.55 | 0.58 | 0.40 | 0.43 | 0.64 | 0.72 | 1.24 | 0.43 | 0.77 | 0.36 | 0.65 | 0.21 | 0.17 | 0.20 | 0.82 | 0.48 | 0.62 | 0.63 | 0.45 | 0.62 | 0.07 | 0.54 | 0.45 | 0.63 | 0.63 | 0.80 | 0.89 | - | 0.69 | 0.93 | 0.93 | - | 0.79 |
| R&D Expense | 23.00M | - | 25.00M | 27.00M | 23.00M | - | 42.00M | 44.00M | 45.00M | - | 41.00M | 50.00M | 46.00M | - | 51.00M | 47.00M | 44.00M | - | 49.00M | 44.00M | 45.00M | - | 50.00M | 53.00M | 49.00M | 52.00M | 53.00M | 47.00M | 53.00M | 58.00M | 61.00M | 59.00M | 58.00M | 55.00M | - | 56.00M | 58.00M | 52.00M | - | 56.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Oct 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.85B | 3.20B | - | 3.80B | 3.79B | 3.84B | 3.92B | 3.65B | 3.77B | 4.71B | 5.21B | 5.25B | 4.88B | - | 5.52B | 7.36B | 8.56B | 9.04B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.44B | 4.65B | 5.35B | 5.56B |
| Gross Profit | 1.04B | 1.21B | - | 1.46B | 1.50B | 1.50B | 1.51B | 1.40B | 1.46B | 1.85B | 2.03B | 2.05B | 1.83B | - | 2.08B | 2.72B | 3.21B | 3.48B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.43B | 1.99B | 2.14B | 2.15B |
| Operating Income | 276.00M | 388.00M | - | 395.00M | 443.00M | 363.00M | 463.00M | 449.00M | 408.00M | 552.00M | 654.00M | 486.00M | 367.00M | - | 651.00M | 728.00M | 1.07B | 1.33B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 726.00M | 1.12B | 1.69B | 1.78B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.00M | 49.00M | 44.00M | 29.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 440.00M | 635.00M | 1.09B | 1.18B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 85.00M | 26.00M | 197.00M | 231.00M |
| Net Income | 263.00M | 329.00M | 220.00M | 279.00M | 297.00M | 228.00M | 337.00M | 340.00M | 260.00M | 331.00M | 549.00M | 401.00M | 254.00M | - | 355.00M | 609.00M | 890.00M | 957.00M |
| Diluted EPS | 1.42 | 1.78 | - | 1.50 | 1.59 | 1.22 | 1.83 | 1.87 | 1.45 | 1.83 | 3.03 | 2.21 | 1.40 | - | 1.96 | 2.79 | 3.65 | 3.92 |
| R&D Expense | 63.00M | 74.00M | - | 100.00M | 106.00M | 104.00M | 104.00M | 95.00M | 110.00M | 181.00M | 189.00M | 191.00M | 187.00M | 204.00M | 206.00M | 232.00M | 230.00M | 226.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 3.73B | 4.40B | 4.68B | 4.86B | 4.83B | 4.66B | 6.47B | 6.86B | 7.22B | 7.71B | 8.75B | - | 7.95B | 16.11B | 16.49B | 17.63B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.01B | 3.88B | 4.10B | 4.64B |
| Cash & Equivalents | 81.00M | 131.00M | 131.00M | 318.00M | 504.00M | 533.00M | 663.00M | 680.00M | 308.00M | 414.00M | 296.00M | 724.00M | 1.88B | - | 944.00M | 1.02B | 1.12B | 1.48B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 799.00M | 1.02B | 996.00M | 983.00M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.10B | 1.62B | 1.67B | 1.76B |
| Total Liabilities | - | - | 1.02B | 2.57B | 2.60B | 2.65B | 2.71B | 2.57B | 4.27B | 4.34B | 4.44B | 4.74B | 5.77B | - | 4.45B | 5.94B | 5.61B | 5.88B |
| Current Liabilities | - | - | 649.00M | 817.00M | 781.00M | 853.00M | 903.00M | 823.00M | 1.24B | 1.10B | 1.39B | 1.50B | 1.96B | - | 1.59B | 2.21B | 2.34B | 2.86B |
| Long Term Debt | - | - | 4.00M | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 2.11B | 2.20B | 2.05B | 2.04B | 2.48B | - | 1.88B | 2.27B | 1.98B | 1.41B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.95B | 2.39B | 2.12B | 2.06B |
| Total Equity | 1.64B | 1.69B | 2.72B | 1.83B | 2.07B | 2.24B | 2.13B | 2.08B | 2.19B | 2.50B | 2.77B | 2.96B | 2.97B | - | 3.49B | 10.17B | 10.64B | 11.48B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 196.00M | 257.60M | 259.20M | 259.88M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 370.00M | 395.00M | 449.00M | 396.00M | 324.00M | 416.00M | 464.00M | 497.00M | 686.00M | 586.00M | 839.00M | 824.00M | - | 596.00M | 837.00M | 1.26B | 1.24B |
| Investing Cash Flow | -84.00M | -1.09B | -423.00M | -147.00M | -199.00M | -86.00M | -132.00M | -1.89B | -181.00M | -643.00M | -231.00M | -169.00M | - | -191.00M | -628.00M | -482.00M | -471.00M |
| Financing Cash Flow | -292.00M | 745.00M | 172.00M | -74.00M | -100.00M | -147.00M | -262.00M | 1.03B | -421.00M | -40.00M | -177.00M | 473.00M | - | -790.00M | -157.00M | -615.00M | -501.00M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -208.00M | -271.00M | -321.00M | -331.00M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | 388.00M | 566.00M | 942.00M | 910.00M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -385.00M | 52.00M | 166.00M | 269.00M |
| Share Buybacks | - | 0 | 0 | 13.00M | 73.00M | 134.00M | 179.00M | 4.00M | 25.00M | 59.00M | 40.00M | 61.00M | 68.00M | 52.00M | 25.00M | 20.00M | 15.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Oct 2011 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 36.4% | 37.9% | - | 38.4% | 39.6% | 39.1% | 38.6% | 38.4% | 38.8% | 39.2% | 38.9% | 39.0% | 37.5% | - | 37.7% | 36.9% | 37.5% | 38.5% |
| Operating Margin % | 9.7% | 12.1% | - | 10.4% | 11.7% | 9.5% | 11.8% | 12.3% | 10.8% | 11.7% | 12.6% | 9.3% | 7.5% | - | 11.8% | 9.9% | 12.5% | 14.7% |
| Net Margin % | 9.2% | 10.3% | - | 7.3% | 7.8% | 5.9% | 8.6% | 9.3% | 6.9% | 7.0% | 10.5% | 7.6% | 5.2% | - | 6.4% | 8.3% | 10.4% | 10.6% |
| ROE % | 15.6% | 12.1% | - | 15.2% | 14.3% | 10.2% | 15.8% | 16.3% | 11.9% | 13.2% | 19.8% | 13.6% | 8.6% | - | 10.2% | 6.0% | 8.4% | 8.3% |
| ROCE % | - | 12.6% | - | 11.0% | 11.4% | 9.1% | 11.8% | 11.7% | 7.8% | 9.6% | 11.2% | 7.8% | 5.4% | - | 10.2% | 5.2% | 7.6% | 9.0% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 10.79% | 25.65M | $3.12B |
| 2 | Vanguard Capital Management LLC | 6.65% | 15.82M | $1.92B |
| 3 | Vanguard Portfolio Management LLC | 5.37% | 12.77M | $1.55B |
| 4 | State Street Corporation | 4.70% | 11.17M | $1.36B |
| 5 | Geode Capital Management, LLC | 2.70% | 6.41M | $778.31M |
| 6 | Swedbank AB | 2.33% | 5.53M | $671.11M |
| 7 | Amundi | 2.20% | 5.23M | $634.95M |
| 8 | Royal Bank of Canada | 2.00% | 4.76M | $578.40M |
| 9 | Impax Asset Management Group plc | 1.93% | 4.59M | $556.82M |
| 10 | Pictet Asset Management Holding SA | 1.82% | 4.33M | $526.37M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XYL
Is Xylem (XYL) A Bargain After Its Executive Leadership Changes? - simplywall.st
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNbmpIOWl3R0g5R01jY3FrNGY3SnZDOEx5Y2F5R05Db3VVeFdLR1NCb1RBQmhnd0NDRE5RcTQ1U2V3dmRYOHZLREhnX0V3MDhDVmJUTjFrS1RfQ0dmalItR2U3WHE0WU5CbkJwYXhPLWJNOEZmUTN2aHNIWTBXcms5YnUxYlZJRFJoOVk3MG…
Reassessing Xylem (XYL) Valuation After A 21% Year To Date Share Price Pullback - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNWjJnVmx1ODEtblJ6SExCWXh3Ymt3U2xRYUotNXBTNDRDbjlVaE5zYmVXZFlNaFNYRzRCOFJvTzFxREVjLWl5bjVNWV9JeEo0S3pxLWxoRk9IR2Vfb0pucS14VDNPVnluMGE0RFFnYjF4UF93MnpfWVRrSmUzMXl0RV9QdVY0SFdRQmVHTF…
2 Industrials Stocks with Promising Prospects and 1 Facing Headwinds - StockStory
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxNanBTZXRpTmljMGtQbkp0Mk8wLTBhZEtfTzFWR0VqcXFjYWZtNnJ5ZDJLeE9yN3pmLWNZU2hPZ0I4MGhKSnh4MFF3OHA5OXZXYS03Qks4bVBveVlrSWtfLURsYV9uelBpeS0wZnN6cXBWdnVUTzctZ1k4TkZmNjFMWUY5TG1qWVU0RHJTN2…
Xylem (XYL) Short Interest & Short Float | Updated Jul 2026 $XYL - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9qa2ctdUx6b3B4U0xYbEFnQmp0SnFKUERjd3ZkN3gtUVlYeDhhaFYyNGtvZnlKQm1XbEZEV0J2aGExbVNQR0dybmhCbUFCZF9nZnp5ek1DbXFDb2M3Qmx4QU1GWmJkYk1PVWc?oc=5" target="_blank">Xylem (XYL) Short Intere…
Xylem: Turn Water Into Cash Flow (NYSE:XYL) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE50WmU0Y0FmT1U1UXRXQUN4MFl2ZkxvMlZ0SG53Z2lmWmFkSDNTVlY2bHo2b3RWekZjWFduejlIeXZYdVdXWktkTFNiSGF1d05VYW41M2dVeDA2cHVjd0pXdHRhZHhyN2lTNTVfTS1jbDdseGo1ZldMcnhrakE?oc=5" target="_blank">…
Trading the Move, Not the Narrative: (XYL) Edition - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNZUkzWDNqTGI4V3NjT1lGX1o5ZlVVNEI4S29tRERsMGpJc2kxZ2YtRXFVOXptXy1KU05zSHF6eElKTF81WUlpbDgzRHdpR0RObl9yb25malNfOXlBZnN3Z2pZODRxNVQ1SXNBc0drR2JzUkUyMU9FcGZsdHRQZkNtYWpIYmJoc1JwS0hiRV…
XYL — Frequently Asked Questions
What is the current share price of Xylem Inc. (XYL)?
As of 2026-07-15 16:51 PDT, Xylem Inc. (XYL) trades at $121.43 on NYSE. Its 52-week range is $105.92 to $151.41.
What is the market capitalisation of XYL?
Xylem Inc. (XYL) has a market capitalisation of $28.86B on NYSE.
What is the P/E ratio of XYL?
XYL trades at a trailing price-to-earnings (P/E) ratio of 30.21. The industry average P/E is 30.16. Its price-to-book (P/B) ratio is 2.51.
Does XYL pay a dividend?
Xylem Inc. (XYL) currently offers a dividend yield of 1.46%.
What is the return on equity (ROE) of XYL?
XYL has a return on equity (ROE) of 8.72%. Its return on capital employed (ROCE) is 8.19%.
Is XYL a good stock to buy?
This page provides a data-driven analysis of Xylem Inc. (XYL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.